未来心房颤动抗栓——谁主沉浮

被引:4
作者
陈敏华
王兴祥
机构
[1] 浙江大学医学院附属第一医院心内科
关键词
心房颤动; 抗栓治疗; 直接凝血酶抑制剂; Ⅹa因子抑制剂; REG1;
D O I
暂无
中图分类号
R541.75 [];
学科分类号
摘要
心房颤动(房颤)是导致缺血性脑卒中的主要危险因素,因此抗栓治疗是房颤治疗的核心。目前临床上最常用的抗栓药物是华法林,但其具有治疗窗窄、易出血、需定期监测凝血功能等缺陷,需要我们去积极探索新的抗栓药物。直接凝血酶抑制剂、Ⅹa因子抑制剂及REG1等药物的发现给房颤抗栓治疗带来了新的曙光。这些药物大多已被多项临床试验结果证明具有抗栓作用,且可以弥补华法林的不足,至于能否替代华法林用于房颤的抗栓治疗,有待正在进行或正在积极准备的相关研究来回答。现回顾近年来相关临床研究的结果,分析目前新型抗凝药物中谁最有可能主导未来房颤的抗栓治疗。
引用
收藏
页码:185 / 189
页数:5
相关论文
共 6 条
[1]   中国心房颤动现状的流行病学研究 [J].
周自强 ;
胡大一 ;
陈捷 ;
张仁汉 ;
李奎宝 ;
赵秀丽 .
中华内科杂志, 2004, (07) :15-18
[2]   Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation:: a randomised, open-label, non-inferiority trial [J].
Bousser, M. G. ;
Bouthier, J. ;
Buller, H. R. ;
Cohen, A. T. ;
Crijns, H. ;
Davidson, B. L. ;
Halperin, J. ;
Hankey, G. ;
Levy, S. ;
Pengo, V. ;
Prandoni, P. ;
Prins, M. H. ;
Tomkowski, W. ;
Thorp-Pedersen, C. ;
Wyse, D. G. .
LANCET, 2008, 371 (9609) :315-321
[3]   Dabigatran with or without concomitant Aspirin compared with Warfarin alone in patients with nonvalvular atrial fibrillation (PETRO study) [J].
Ezekowitz, Michael D. ;
Reilly, Paul A. ;
Nehmiz, Gerhard ;
Simmers, Timothy A. ;
Nagarakanti, Rangadham ;
Parcham-Azad, Kambiz ;
Pedersen, K. Erik ;
Lionetti, Dominick A. ;
Stangier, Joachim ;
Wallentin, Lars .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (09) :1419-1426
[4]   First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology - A phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity [J].
Dyke, Christopher K. ;
Steinhubl, Steven R. ;
Kleiman, Neal S. ;
Cannon, Richard O. ;
Aberle, Laura G. ;
Lin, Min ;
Myles, Shelley K. ;
Melloni, Chiara ;
Harrington, Robert A. ;
Alexander, John H. ;
Becker, Richard C. ;
Rusconi, Christopher P. .
CIRCULATION, 2006, 114 (23) :2490-2497
[5]   Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence [J].
Miyasaka, Yoko ;
Barnes, Marion E. ;
Gersh, Bernard J. ;
Cha, Stephen S. ;
Bailey, Kent R. ;
Abhayaratna, Walter P. ;
Seward, James B. ;
Tsang, Teresa S. M. .
CIRCULATION, 2006, 114 (02) :119-125
[6]   Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial [J].
Connolly, S. ;
Pogue, J. ;
Hart, R. ;
Pfeffer, M. ;
Hohnloser, S. ;
Chrolavicius, S. ;
Yusuf, S. .
LANCET, 2006, 367 (9526) :1903-1912